Kwell en es it fr

Kwell Brand names, Kwell Analogs

Kwell Brand Names Mixture

  • No information avaliable

Kwell Chemical_Formula


Kwell RX_link

No information avaliable

Kwell fda sheet

Kwell msds (material safety sheet)

Kwell Synthesis Reference

No information avaliable

Kwell Molecular Weight

303.353 g/mol

Kwell Melting Point

No information avaliable

Kwell H2O Solubility

No information avaliable

Kwell State


Kwell LogP


Kwell Dosage Forms


Kwell Indication

For the treatment of excessive salivation, colicky abdominal pain, bradycardia, sialorrhoea, diverticulitis, irritable bowel syndrome and motion sickness.

Kwell Pharmacology

Scopolamine is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors and is thus classified as an anticholinergic. Scopolamine has many uses including the prevention of motion sickness. It is not clear how Scopolamine prevents nausea and vomiting due to motion sickness. The vestibular part of the ear is very important for balance. When a person becomes disoriented due to motion, the vestibule sends a signal through nerves to the vomiting center in the brain, and vomiting occurs. Acetylcholine is a chemical that nerves use to transmit messages to each other. It is believe that Scopolamine prevents communication between the nerves of the vestibule and the vomiting center in the brain by blocking the action of acetylcholine. Scopolamine also may work directly on the vomiting center. Scopolamine must be taken before the onset of motion sickness to be effective.

Kwell Absorption

No information avaliable

Kwell side effects and Toxicity

No information avaliable

Kwell Patient Information

No information avaliable

Kwell Organisms Affected

Humans and other mammals